Sphingosine 1-phosphate-metabolizing enzymes control influenze virus amplification and the viral cyto-pathogenicity [abstract] by Seo, Young-Jin
 SPHINGOSINE 1-PHOSPHATE-METABOLIZING ENZYMES CONTROL 
INFLUENZA VIRUS AMPLIFICATION AND THE VIRAL CYTO-
PATHOGENICITY 
 
Young-Jin Seo (Postdoctoral Fellow) 
 
 (Bumsuk Hahm, PhD) 
Celeste Blake 
School of Medicine, Departments of Surgery and  
Molecular Microbiology & Immunology 
Stephen Alexander, PhD 
College of Arts and Science, Division of Biological Sciences 
 
Sphingosine 1-phosphate (S1P) is regulated by cellular catalytic enzymes and has 
diverse biological functions. However, the effects that S1P-catalyzing enzymes have 
on host defense and immunity to invading viruses remain unknown. In this study, we 
investigated the role of S1P-metabolyzing enzymes in modulating cellular responses 
to influenza virus infection. Over-expression of S1P lyase (SPL), which induces 
degradation of S1P on cells (SPL-cells), interfered with the propagation of influenza 
virus. Accordingly, SPL-cells were much more resistant to the cytopathic effects 
caused by influenza virus infection than the control cells. SPL-mediated inhibition of 
cellular death was supported by impairment of the upregulation of a pro-apoptotic 
protein Bax, a critical factor for influenza viral cyto-pathogenicity. Importantly, the 
virus-infected SPL-cells induced early activation of STAT1 and STAT2 that are 
representative proteins for the anti-viral type I IFN signaling. These results suggest 
that SPL suppresses influenza virus replication via rapid activation of host innate 
immunity. In contrast to the SPL, the over-expression of S1P-producing sphingosine 
kinase 1 heightened the cells’ susceptibility to influenza viral infection with 
suppressed STAT1 activation, representing opposed enzymatic activity. These 
findings suggest that the modulation of S1P-metabolyzing enzymes is crucial for 
controlling host innate immunity and resultant host defense against influenza viral 
infection. Thus, S1P-metabolizing enzymes are novel potential targets to treat 
diseases caused by influenza virus infection.  
 
